Stocktoria
MESA LABORATORIES INC /CO/ MLAB
MESA LABORATORIES INC /CO/ (MLAB) earns a Piotroski F-score of 8/9 (strong financial health), with an Altman Z″ in the distress zone. It pays a dividend yielding 0.62% (safety: moderate). FY2026 revenue was $249.1M at a 2.7% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.81 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 8/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.104 |
| Retained earnings / assets | -0.434 |
| EBIT / assets | 0.043 |
| Equity / liabilities | 0.771 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| MLAB | MESA LABORATORIES INC /CO/ | 8/9 | 0.37 | 84.3 | +3.4% |
| HURC | HURCO COMPANIES INC | 4/9 | 9.02 | — | -4.3% |
| SYPR | SYPRIS SOLUTIONS INC | 2/9 | -2.92 | — | -14.5% |
| SENS | Senseonics Holdings, Inc. | 6/9 | — | — | +56.9% |
| INIS | RADNOSTIX INC | 3/9 | — | — | -6% |
| ELSE | ELECTRO SENSORS INC | 5/9 | — | 88.3 | — |
| CLIR | ClearSign Technologies Corp | 2/9 | — | — | — |
About MESA LABORATORIES INC /CO/
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
FAQ
Is MLAB financially healthy?
MESA LABORATORIES INC /CO/'s Piotroski F-score is 8/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does MLAB pay a dividend, and is it safe?
Yes. MESA LABORATORIES INC /CO/ pays a dividend yielding about 0.62% with a 52.5% payout ratio, rated “moderate” for safety.
How profitable is MLAB?
In FY2026, MESA LABORATORIES INC /CO/ had a net margin of 2.7% and a return on equity of 3.6%.
Is MLAB overvalued or undervalued?
MESA LABORATORIES INC /CO/ trades at about 93.2× trailing earnings — below its 10-year norm (10-year range 32.3×–979.5×, median 127.3×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for MLAB?
The average Wall-Street price target for MESA LABORATORIES INC /CO/ is $112.00, about 0.7% below the recent price, from 2 analysts.
Is MLAB a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on MESA LABORATORIES INC /CO/: a Piotroski F-score of 8/9, an Altman Z″ in the distress zone, a P/E of about 84.3×, a dividend yield of 0.62%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2026-03-31. Facts plus Stocktoria's own computed scores — not investment advice.